![]() |
|
|

Loyola University Medical Center Stritch School of Medicine, Maywood, IL 60153;
*
University of Catania, Institute of Geriatrics and Gerontology, Catania, Italy;
Cornelli Consulting, Milano, Italy; and
**
CNR I.Co.C.E.A., Area della Ricerca di Bologna, I-40129 Bologna, Italy
1To whom correspondence should be addressed. E-mail: corcon{at}katamail.com.
Most antioxidants show contradictory behaviors because in the biological environment, for unpredictable reasons, they can become prooxidants. Recently, a new simple method to monitor oxidative stress in serum was developed. This test detects the derivatives of reactive oxygen metabolites (D-Roms). Hydroperoxides are converted into radicals that oxidize N,N-diethyl-para-phenylendiamine and that can be detected through spectrophotometric procedures as U.CARR. (Carratelli units). One U.CARR. corresponds to 0.8 mg/L hydrogen peroxide. In normal subjects U.CARR. values range from 250 to 300. Values outside this range indicate a modification of the prooxidant/antioxidant ratio. On the basis of this method, we tested three different formulas of antioxidants (F1, F2, F3) in 14 apparently healthy volunteers (11 men and 3 women). Formula 1 was composed of 5 mg zinc, 48 µg selenium, 400 µg vitamin A (as retinol acetate), 50 µg ß-carotene, 15 mg vitamin E (as dl-
-tocopheryl acetate) and 10 mg L-cysteine. Formula 2 was composed of 30 mg bioflavonoids from citrus, 30 mg vitamin C (as L-ascorbic acid), 10 mg coenzyme Q10 and 1 mg vitamin B-6 (as pyridoxine hydrochloride). Formula 3 was composed of Formula 1 plus Formula 2. Each formula was prepared in dry capsules (formulation D1, D2, D3) or in a fluid form (formulation P1, P2, P3). Each formulation was administered for 1 wk in a crossover design. A 15% deviation of U.CARR. levels was chosen as the cut-off value for a significant change in oxidative stress. Formulas F1 and F3 reduced mean U.CARR. levels in most of the treated subjects (t test, P < 0.05), whereas F2 was not active. Fluid formulations were more active than dry formulations (
2 test, P < 0.05). In some cases, a slight increase in oxidative stress was detected. These minimal increases were not related to any particular antioxidant formula. In one subject only, the administration of the dry formulation (D1), increased oxidative stress to a level that reached the cut-off value. In conclusion, when antioxidants are taken in combination at low dosages they reduce oxidative stress, and little relevant prooxidant activity is detectable.
KEY WORDS: antioxidants prooxidants D-Roms test bioavailability crossover study humans
This article has been cited by other articles:
![]() |
M. Tsuchiya, E. F. Sato, M. Inoue, and A. Asada Open Abdominal Surgery Increases Intraoperative Oxidative Stress: Can It Be Prevented? Anesth. Analg., December 1, 2008; 107(6): 1946 - 1952. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takahashi, S. Yamaguchi, T. Shimoyama, H. Seki, K. Miyokawa, H. Katsuta, T. Tanaka, K. Yoshimoto, H. Ohno, S. Nagamatsu, et al. JNK- and I{kappa}B-dependent pathways regulate MCP-1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E898 - E909. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. De Cosmo, O. Lamacchia, A. Rauseo, R. Viti, L. Gesualdo, A. Pilotti, V. Trischitta, and M. Cignarelli Cigarette smoking is associated with low glomerular filtration rate in male patients with type 2 diabetes. Diabetes Care, November 1, 2006; 29(11): 2467 - 2470. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Reid, A. Badaloo, T. Forrester, and F. Jahoor In vivo rates of erythrocyte glutathione synthesis in adults with sickle cell disease Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E73 - E79. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cighetti, R. Paroni, S. Marzorati, E. Borotto, R. Giudici, G. Magnanini, and G. Iapichino Evaluation of Oxidative Stress in Serum of Critically Ill Patients by a Commercial Assay and Gas Chromatography-Mass Spectrometry Clin. Chem., August 1, 2005; 51(8): 1515 - 1517. [Full Text] [PDF] |
||||
![]() |
A. Maccio, C. Madeddu, D. Massa, M. C. Mudu, M. R. Lusso, G. Gramignano, R. Serpe, G. B. Melis, and G. Mantovani Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia Blood, July 1, 2005; 106(1): 362 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A Jackson, N. R Gibson, Y. Lu, and F. Jahoor Synthesis of erythrocyte glutathione in healthy adults consuming the safe amount of dietary protein Am. J. Clinical Nutrition, July 1, 2004; 80(1): 101 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M Ridker, N. J. Brown, D. E. Vaughan, D. G. Harrison, and J. L. Mehta Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events Circulation, June 29, 2004; 109(25_suppl_1): IV-6 - IV-19. [Full Text] [PDF] |
||||
![]() |
S. S. Sarang, T. Yoshida, R. Cadet, A. S. Valeras, R. V. Jensen, and S. R. Gullans Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays Physiol Genomics, October 29, 2002; 11(2): 45 - 52. [Abstract] [Full Text] [PDF] |
||||